Commission Implementing Regulation (EU) 2019/716 of 30 April 2019 amending Implementing Regulations (EU) No 22/2013 and (EU) No 540/2011 as regards the conditions of approval of the active substance cyflumetofen (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/716 of 30 April 2019 amending Implementing Regulations (EU) No 22/2013 and (EU) No 540/2011 as regards the conditions of approval of the active substance cyflumetofen (Text with EEA relevance.)

Preamble 1

recital 1recital 1

recital 2recital 2

recital 3recital 3

recital 4recital 4

recital 5recital 5

recital 6recital 6

recital 7recital 7

recital 8recital 8

recital 9recital 9

recital 10recital 10

recital 11recital 11

recital 12recital 12

recital 13recital 13

recital 14recital 14

Article 1Amendment to Implementing Regulation (EU) No 22/2013

Article 2Amendment to Implementing Regulation (EU) No 540/2011

Article 3Transitional measures

Article 4Grace period

Article 5Entry into force

Annex IANNEX I

Annex IIANNEX II